Abstract
Purpose
This study was undertaken to evaluate risk factors for the occurrence of postoperative abscesses in a large single-institution series of gynecologic cancer patients undergoing major surgery.
Materials and Methods
Patients admitted to the Division of Gynecologic Oncology, Catholic University of Sacred Hearth, Rome, Italy, between January 2008 and February 2009, were retrospectively analyzed. The occurrence of pelvic abscesses was identified by sign and symptoms and confirmed with radiological and microbiological examinations.
Results
A total of 360 patients were analyzed for the study. Exenteration and use of fibrillar absorbable hemostat were significantly associated with the presence of postoperative abscesses (P < .0001) by multiple regression analysis, whereas operative time, type of surgery, lymphadenectomy, or other associated surgical procedures failed to result statistically relevant.
Conclusions
The use of fibrillar oxidized regenerated cellulose as hemostatic agent may represent a risk factor for postoperative abscesses, especially when used during pelvic exenteration.
Similar content being viewed by others
References
Kehoe S. Treatments for gynecological cancers. Best Pract Res Clin Obstet Gynaecol. 2006;20:985–1000.
Chan KK, Naik R. Advances in surgical treatment of cervical cancer. Womens Health (Lond Engl). 2008;4:245–56.
Benedetti-Panici P, Maneschi F, Cutillo G, Greggi S, Salerno MG, Amoroso M, et al. G. Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical results. Cancer. 1996;78:2359–65.
Van der Burg ME, Vergote I. Gynecological Cancer Group of the EORTC. The role of interval debulking surgery in ovarian cancer. Curr Oncol Rep. 2003;5:473–81.
Bosze P, Meszaros I, Palfalvi L, Ungar L. Perioperative complications of 116 radical hysterectomies and pelvic node dissections. Eur J Surg Oncol. 1993;19:605–8.
Zorlu CG, Aydoğdu T, Ergün Y, Kuşçu E, Cobanoğlu O, Koçak S. Complications of radical hysterectomy: clinical experience of 115 early stage cervical cancers. Gynecol Obstet Invest. 1998;45:137–9.
Gadducci A, Cosio S, Spirito N, Genazzani AR. The perioperative management of patients with gynaecological cancer undergoing major surgery: a debated clinical challenge. Crit Rev Oncol Hematol. 2010;73:126–40.
Dicker RC, Greenspan JR, Strauss LT, Cowart MR, Scally MJ, Peterson HB, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol. 1982;144:841–84.
Fanning J, Neuhoff RA, Brewer JE, Castaneda T, Marcotte MP, Jacobson RL. Frequency and yield of postoperative fever evaluation. Infect Dis Obstet Gynecol. 1998;6:252–5.
Tanos V, Rojansky N. Prophylactic antibiotics in abdominal hysterectomy. J Am Coll Surg. 1994;179:593–600.
Ailawadi M. and Del Priore G. A comparison of thromboembolic prophylaxis in gynecologic oncology patients. Int J Gynecol Cancer. 2001;11:354–8.
ACOG Committee on Practice Bulletins. Antibiotic prophylaxis for gynecologic procedures. ACOG Practice Bulletin No. 74. Obstet Gynecol. 2006;108:225–34.
Oliveira L, Wexner SD, Daniel N, DeMarta D, Weiss EG, Nogueras JJ, et al. Mechanical bowel preparation for elective colorectal surgery. A prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions. Dis Colon Rectum. 1997;40:585–91.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
Cox DR. Analysis of binary data. London: Methven; 1970.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–78.
Leitao MM Jr, Natenzon A, Abu-Rustum NR, Chi DS, Sonoda Y, Levine DA, et al. Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers. Gynecol Oncol. 2009;115:204–8.
Mazeh H, Samet Y, Abu-Wasel B, Beglaibter N, Grinbaum R, Cohen T, et al. Application of a novel severity grading system for surgical complications after colorectal resection. J Am Coll Surg. 2009;208:355–61.
Bochner BH, Mc Creath WA, Aubey JJ. Use of ureteroileocecalappendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation. Gynecol Oncol. 2004;94:140–6.
Caceres A, Mourton SM, Bochner BH, Gerst SR, Liu L, Alektiar KM, et al. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. Int J Gynecol Cancer. 2008;18:1139–44.
Spangler D, Rothenburger S, Nguyen K, Jampani H, Weiss S, Bhende S. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect (Larchmt). 2003;4:255–62.
Scher KS, Coil JA Jr. Effects of oxidized cellulose and microfibrillar collagen on infection, Surgery. 1982;91:301–4.
Vytrasova J, Tylsova A, Brozkova I, Cervenka L, Pejchalova M, Havelka P. Antimicrobial effect of oxidized cellulose salts. J Indian Microbiol Biotechnol. 2008;35:1247–52.
Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004;13:S89–96.
Kothbauer KF, Jallo GI, Siffert J, Jimenez E, Allen JC, Epstein FJ. Foreign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases. J Neurosurg. 2001;95:503–6.
Gao HW, Lin CK, Yu CP, Yu MS, Chen A. Oxidized cellulose (Surgicel) granuloma mimicking a primary ovarian tumor. Int J Gynecol Pathol. 2002;21:422–3.
Ereth MH, Schaff M, Ericson EF, Wetjen NM, Nuttall GA, Oliver WC Jr. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery. 2008;63:369–72.
Toglia MR, Pearlman MD. Pelvic fluid collections following hysterectomy and their relation to febrile morbidity. Obstet Gynecol. 1994;83:766–70.
Bjorenson JE, Grove HF, List MG Sr, Haasch GC, Austin BP. Effects of hemostatic agents on the pH of body fluids. J Endod. 1986;12:289–92.
McRitchie DI, Girotti MJ, Glynn MF, Goldberg JM, Rotstein OD. Effect of systemic fibrinogen depletion on intra-abdominal abscess formation. J Lab Clin Med. 1991;118:48–55.
Rotstein OD. Role of fibrin deposition in the pathogenesis of intraabdominal infection. Eur J Clin Microbiol Infect Dis. 1992;11:1064–8.
Reijnen MM, Bleichrodt RP, van Goor H. Pathophysiology of intra-abdominal adhesion and abscess formation, and the effect of hyaluronan. Br J Surg. 2003;90:533–41.
Seyednejad H, Imani M, Jamieson T, Seifalian AM. Topical haemostatic agents. Br J Surg. 2008;95:1197–225.
Querleu D, Morrow CP. Classification of radical hysterectomy. Gynecol Oncol. 2009;115:314–5; author reply 315–6.
Acknowledgment
This study is not supported by any grant support. The authors indicate no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fagotti, A., Costantini, B., Fanfani, F. et al. Risk of Postoperative Pelvic Abscess in Major Gynecologic Oncology Surgery: One-Year Single-Institution Experience. Ann Surg Oncol 17, 2452–2458 (2010). https://doi.org/10.1245/s10434-010-1059-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-010-1059-3